Nutex Health swung to profit in Q2, with net income attributable to shareholders of USD 65.84 million versus a loss a year earlier.
Operating income rose to USD 121.72 million, while revenue fell 13.62% to USD 210.75 million.
Adjusted EBITDA (non-GAAP) increased 25.65% to USD 89.99 million.
Patient visits climbed 9.6% to 49,962, while hospital division revenue dropped 14.6% to USD 201.85 million.
Arbitration-related costs totaled USD -12.5 million, reflecting a USD 52.3 million reduction to contract services expense tied to HaloMD and fee changes.
NUTX•
